Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP.

Ghosh AK, Majumder M, Steele R, Yaciuk P, Chrivia J, Ray R, Ray RB.

J Biol Chem. 2000 Mar 10;275(10):7184-8.

2.

Modulation of interferon expression by hepatitis C virus NS5A protein and human homeodomain protein PTX1.

Ghosh AK, Majumder M, Steele R, Ray R, Ray RB.

Virology. 2003 Feb 1;306(1):51-9.

3.

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins.

Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM.

Virology. 2002 Jan 20;292(2):198-210.

5.

Adenovirus DNA binding protein inhibits SrCap-activated CBP and CREB-mediated transcription.

Xu X, Tarakanova V, Chrivia J, Yaciuk P.

Virology. 2003 Sep 1;313(2):615-21.

6.

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein.

Tu H, Gao L, Shi ST, Taylor DR, Yang T, Mircheff AK, Wen Y, Gorbalenya AE, Hwang SB, Lai MM.

Virology. 1999 Oct 10;263(1):30-41.

7.

The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling.

Macdonald A, Crowder K, Street A, McCormick C, Saksela K, Harris M.

J Biol Chem. 2003 May 16;278(20):17775-84. Epub 2003 Mar 5.

8.

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.

Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD.

Oncogene. 2002 Jul 18;21(31):4801-11.

9.

Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication.

Polyak SJ, Paschal DM, McArdle S, Gale MJ Jr, Moradpour D, Gretch DR.

Hepatology. 1999 Apr;29(4):1262-71.

PMID:
10094974
11.

The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.

Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD, Kim SJ, Kim YW, Poo HR.

Oncogene. 1998 May 7;16(18):2367-80.

12.
13.
14.

Specific interaction of Egr1 and c/EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene.

Zhang F, Lin M, Abidi P, Thiel G, Liu J.

J Biol Chem. 2003 Nov 7;278(45):44246-54. Epub 2003 Aug 28.

15.

The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells.

Slupianek A, Yerrum S, Safadi FF, Monroy MA.

J Cell Physiol. 2010 Aug;224(2):369-75. doi: 10.1002/jcp.22132.

PMID:
20432434
18.

Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B.

Hamamoto I, Nishimura Y, Okamoto T, Aizaki H, Liu M, Mori Y, Abe T, Suzuki T, Lai MM, Miyamura T, Moriishi K, Matsuura Y.

J Virol. 2005 Nov;79(21):13473-82.

19.

Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription.

Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, Shiratori Y, Omata M.

J Med Virol. 2004 Jan;72(1):52-9.

PMID:
14635011
20.

Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells.

Satoh S, Hirota M, Noguchi T, Hijikata M, Handa H, Shimotohno K.

Virology. 2000 May 10;270(2):476-87.

Supplemental Content

Support Center